Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Plos One
|
January 8, 2019
Clinical utility of MRI in the decision-making process before radical prostatectomy: Systematic review and meta-analysis
Mieszko Kozikowski, Wojciech Malewski, Wojciech Michalak, et al.
Molecular & Cellular Proteomics : MCP
|
August 27, 2019
ComplexBrowser: A Tool for Identification and Quantification of Protein Complexes in Large-scale Proteomics Datasets
Wojciech Michalak, Vasileios Tsiamis, Veit Schwämmle, et al.
Journal of Medical Economics
|
June 28, 2025
Impact of semaglutide 2.4 mg on healthcare resource utilization and medical costs in patients with atherosclerotic cardiovascular disease in the United States (SHINE-ASCVD)
Wojciech Michalak, Zhenxiang Zhao, Mads Faurby, et al.
Contemporary Oncology (Poznan, Poland)
|
May 6, 2026
Diagnosis, prognostic prediction of the accelerated phase of chronic lymphocytic leukaemia: a narrative review
Krzysztof Michalak, Łukasz Mazur, Alicja Bujara, et al.
Clinical Therapeutics
|
August 14, 2025
Impact of Semaglutide 2.4 mg on Healthcare Resource Utilization and Medical Costs in Patients With Heart Failure in the United States (SHINE-HF)
Wojciech Michalak, Zhenxiang Zhao, Mads Faurby, et al.
Alzheimer Disease and Associated Disorders
|
January 26, 2024
Rescreening on RBANS Delayed Memory Index? Forget About It!
Marwan N Sabbagh, Wojciech Michalak, Charlotte Thim Hansen, et al.
Obesity Science & Practice
|
February 9, 2024
Semaglutide 2.4 mg clinical outcomes in patients with obesity or overweight in a real-world setting: A 6-month retrospective study in the United States (SCOPE)
Aleksandrina Ruseva, Wojciech Michalak, Zhenxiang Zhao, et al.
Advances in Therapy
|
August 6, 2025
Semaglutide 2.4 mg Clinical Outcomes in Patients with Obesity or Overweight: A Real-World Retrospective Comparative Cohort Study
Aleksandrina Ruseva, Wojciech Michalak, Anthony Fabricatore, et al.
Current Medical Research and Opinion
|
December 6, 2025
Sustained weight reduction with once-weekly semaglutide: results from a real-world retrospective cohort study in the United States (SCOPE 24 months)
Aleksandrina Ruseva, Wojciech Michalak, Anthony Fabricatore, et al.
Diabetes, Obesity & Metabolism
|
June 1, 2026
Oral Semaglutide 25 mg Versus Orforglipron 36 mg in Obesity: A Population-Adjusted Indirect Treatment Comparison
Wojciech Michalak, Martin Bøg, Theiss Bendixen, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Plos One
|
January 8, 2019
Clinical utility of MRI in the decision-making process before radical prostatectomy: Systematic review and meta-analysis
Mieszko Kozikowski, Wojciech Malewski, Wojciech Michalak, et al.
Molecular & Cellular Proteomics : MCP
|
August 27, 2019
ComplexBrowser: A Tool for Identification and Quantification of Protein Complexes in Large-scale Proteomics Datasets
Wojciech Michalak, Vasileios Tsiamis, Veit Schwämmle, et al.
Journal of Medical Economics
|
June 28, 2025
Impact of semaglutide 2.4 mg on healthcare resource utilization and medical costs in patients with atherosclerotic cardiovascular disease in the United States (SHINE-ASCVD)
Wojciech Michalak, Zhenxiang Zhao, Mads Faurby, et al.
Contemporary Oncology (Poznan, Poland)
|
May 6, 2026
Diagnosis, prognostic prediction of the accelerated phase of chronic lymphocytic leukaemia: a narrative review
Krzysztof Michalak, Łukasz Mazur, Alicja Bujara, et al.
Clinical Therapeutics
|
August 14, 2025
Impact of Semaglutide 2.4 mg on Healthcare Resource Utilization and Medical Costs in Patients With Heart Failure in the United States (SHINE-HF)
Wojciech Michalak, Zhenxiang Zhao, Mads Faurby, et al.
Alzheimer Disease and Associated Disorders
|
January 26, 2024
Rescreening on RBANS Delayed Memory Index? Forget About It!
Marwan N Sabbagh, Wojciech Michalak, Charlotte Thim Hansen, et al.
Obesity Science & Practice
|
February 9, 2024
Semaglutide 2.4 mg clinical outcomes in patients with obesity or overweight in a real-world setting: A 6-month retrospective study in the United States (SCOPE)
Aleksandrina Ruseva, Wojciech Michalak, Zhenxiang Zhao, et al.
Advances in Therapy
|
August 6, 2025
Semaglutide 2.4 mg Clinical Outcomes in Patients with Obesity or Overweight: A Real-World Retrospective Comparative Cohort Study
Aleksandrina Ruseva, Wojciech Michalak, Anthony Fabricatore, et al.
Current Medical Research and Opinion
|
December 6, 2025
Sustained weight reduction with once-weekly semaglutide: results from a real-world retrospective cohort study in the United States (SCOPE 24 months)
Aleksandrina Ruseva, Wojciech Michalak, Anthony Fabricatore, et al.
Diabetes, Obesity & Metabolism
|
June 1, 2026
Oral Semaglutide 25 mg Versus Orforglipron 36 mg in Obesity: A Population-Adjusted Indirect Treatment Comparison
Wojciech Michalak, Martin Bøg, Theiss Bendixen, et al.
Page
of 3